Advertisement

Analysis of Factors Involved in the Tissue Selectivity of Calcium Antagonists

  • Théophile Godfraind
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 311)

Abstract

In functional studies, the term tissue selectivity is used for an agent showing varying degrees of potency among tissues with a preferential action in a given one. Such a selectivity is well known in the field of β-adrenoceptors, where β1 and β2 agonists and antagonists, differ by the ratio of activity at the level of a given tissue. Usually, this is related to their respective affinities for β1 and β2 adrenoceptors. Selectivity is not specificity which means that a given agent interacts with only one type of receptor. Such an interaction is largely documented in the field of histaminergic receptors where H1 antagonists do not interact with H2 receptors and vice versa. A question that has been raised several times (Godfraind et al., 1986), is the existence of a possible tissue selectivity of calcium antagonists. In other words, does any selectivity exist in the pharmacology of calcium channels ?

Keywords

Calcium Channel Calcium Antagonist Aortic Ring Calcium Entry Calcium Entry Blocker 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Amédée, T., and Large, W. A., 1989, Microelectrode study on the ionic mechanisms which contribute to the noradrenaline-induced depolarization in isolated cells of the rabbit portal vein, Br. J. Pharmacol., 97:1331.PubMedCrossRefGoogle Scholar
  2. Bean, B. P., 1984, Nitrendipine block of cardiac calcium channels: high-affinity binding to the inactivated state, Proc. Natl. Acad. Sci., 81:6388.PubMedCrossRefGoogle Scholar
  3. Bean, B. P., Sturek, M., Puga, A. and Hermsmeyer, K., 1986, Calcium channels in muscle cells isolated from rat mesenteric arteries: modulation by dihydropyridine drugs, Circ. Res., 59:229.PubMedCrossRefGoogle Scholar
  4. Bristow, M. R., Ginsburg, R., Laser, J. A., McAuley, B. J. and Minoba, W., 1984, Tissue response selectivity of calcium antagonists is not due to heterogeneity of [3H]-nitrendipine binding sites, Br. J. Pharmacol. 82:309.PubMedCrossRefGoogle Scholar
  5. Cauvin, C., and Van Bremen, C., 1985, Different Ca2+ channels along the arterial tree, J. Cardiovasc. Pharmacol., 7:54.CrossRefGoogle Scholar
  6. Cauvin, C, and Van Bremen, C, 1985, 45Ca fluxes in isolated rabbit mesenteric resistance vessels as compared to rabbit aorta, Prog. Appl. Microvasc. 8:47.Google Scholar
  7. Chen, G., and Suzuki, H., 1989, Some electrical properties of the endothelium-dependent hyperpolarization recorded from rat arterial smooth muscle cells, J. Physiol. (Lond.). 410:91.PubMedGoogle Scholar
  8. Dunn, W. R., Daly, C. J., McGrath, J. C. and Wilson, V. G., 1991, A comparison of the effects of angiotensin II and Bay K 8644 on responses to noradrenaline mediated via postjunctionnal oci and \ga2-adrenoceptors in rabbit isolated blood vessels, Br. J. Pharmacol.. 103:1475.PubMedCrossRefGoogle Scholar
  9. Féron, O., Wibo, M., and Godfraind, T., 1991, Interaction of Pinaverium bromide with the dihydropyridine binding site in rat ileum smooth muscle, Arch. Int. Pharm. Google Scholar
  10. Godfraind, T., 1983, Actions of nifedipine on calcium fluxes and contraction in isolated rat arteries, J. Pharmacol. Exp. Ther., 224:443.PubMedGoogle Scholar
  11. Godfraind, T., Egleme, C., Finet, M. and Jaumin, P., 1987, The actions of nifedipine and nisoldipine on the contractile activity of human coronary arteries and human cardiac tissue in vitro, Pharmacol. Toxicol., 61:79.PubMedCrossRefGoogle Scholar
  12. Godfraind, T. and Kaba, A., 1969, Inhibition by cinnarizine and chlorpromazine of the contraction induced by calcium and adrenaline in vascular smooth muscle, Br. J. Pharmacol., 35:354P.Google Scholar
  13. Godfraind, T., Miller, R. C., and Wibo, M., 1986, Calcium antagonism and calcium entry blockers, Pharmacol. Rev., 38:321.Google Scholar
  14. Kokubun, S., Prod’Hom, B., Becker, C., Porzig, H., and Reuter, H., 1986, Studies on Ca channels in intact cardiac cells voltage -dependent effects and cooperative interactions of dihydropyridine enantiomers, Mol. Pharmacol., 30:571.PubMedGoogle Scholar
  15. Marriott, J. F., 1988, Comparison of the effects of the calcium entry blockers, verapamil, diltiazem and flunarizine against contractions of the rat isolated aorta and portal vein, Br. J. Pharmacol., 95:145.PubMedCrossRefGoogle Scholar
  16. McKenna, E., Koch, W. J., Slish, D. F., and Schwartz, A., 1990, Toward an understanding of the dihydropyridine-sensitive calcium channel, Biochem. Pharmacol., 39:1145.PubMedCrossRefGoogle Scholar
  17. Morel, N., and Godfraind, T., 1987, Prolonged depolarization increases the pharmacological effect of dihydropyridines and their binding affinity for calcium channels of vascular smooth muscle, J. Pharmacol. Exp. Ther., 243:711.PubMedGoogle Scholar
  18. Morel, N., and Godfraind, T., 1988, Selective modulation by membrane potential of the interaction of some calcium entry blockers with calcium channels in rat mesenteric artery, Br. J. PHarmacol., 95:252.PubMedCrossRefGoogle Scholar
  19. Morel, N., and Godfraind, T., 1989, Pharmacological properties of voltage-dependent calcium channles in functional microvessels isolated from rat brain, Naunyn-Schmiedeberg’s Arch. Pharmacol., 340:442.CrossRefGoogle Scholar
  20. Morel, N., and Godfraind, T., 1991, Characterization in rat aorta of the binding sites responsible for blockade of noradrenaline-evoked calcium entry and contraction by nisoldipine, Br. J. Pharmacol., 102:467.PubMedCrossRefGoogle Scholar
  21. Pacaud, P., Loirand, G., Mironneau, C., and Mironneau, J., 1989, Noradrenaline activates a calcium-activated chloride conductance and increases the voltage-dependent calcium current in cultured single cells of rat portal vein, Br. J. Pharmacol., 97:139.PubMedCrossRefGoogle Scholar
  22. Sanguinetti, M. C, and Kass, R. S., 1984, Voltage-dependent block of calcium channel current in the calf cardiac Purkinje fiber by dihydropyridine calcium channel antagonists, Circ. Res., 55:336.PubMedCrossRefGoogle Scholar
  23. Sumimoto, K, Hirata, M., and Kuriyama, H., 1988, Characterization of [3H]nifedipine binding to intact vascular smooth muscle cells, Am. J. Phvsiol., 254:C45.Google Scholar
  24. Tsien, R.W., 1983, Calcium channels in excitable cell membranes, Annu. Rev. Phvsiol., 45:341.CrossRefGoogle Scholar
  25. White, D. G., and Martin, W., 1989, Differential control and calcium-dependence of production of endothelium-derived relaxing factor and prostacyclin by pig aortic endothelial cells, Br. J. Clin. Pharmacol., 97:683.Google Scholar
  26. Wibo, M., De Roth, L., and Godfraind, T., 1988, Pharmacological relevance of dihydropyridine binding sites in membrane from rat aorta: kinetic and equilibrium studies, Circ. Res., 62:91.PubMedCrossRefGoogle Scholar
  27. Wibo, M., 1989, Mode of action of calcium antagonists: voltage-dependence and kinetics of drug-receptor interaction, Pharmacol. Toxicol., 65:1.PubMedCrossRefGoogle Scholar
  28. Yatani, A., Codina, J., Imoto, Y., Reeves, J. P., Birnbaumer, L., and Brown, A. M., 1987, A G protein directly regulates mammalian cardiac calcium channels, Science. 238:1288.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1992

Authors and Affiliations

  • Théophile Godfraind
    • 1
  1. 1.Laboratoire de Pharmacologie, UCL 7350Université Catholique de LouvainBrusselsBelgium

Personalised recommendations